United States · FDA National Drug Code directory
Azelastine hydrochloride and Fluticasone propionate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-0953_7497532a-03c9-9016-0df5-6d3acfc3b29b
- Product NDC
- 60505-0953
- Form
- SPRAY, METERED
- Composition / generic term
- Azelastine hydrochloride and Fluticasone propionate
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200302
- Source listing expiry
- 20271231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — 137 ug/1
- FLUTICASONE PROPIONATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 CARTON (60505-0953-3) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · 60505-0953-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →